LabConnect has announced a new partnership with Kits4Life, an initiative of the MedSurplus Alliance. This collaboration supports LabConnect’s broader ESG strategy and reinforces its position as a leader in sustainable central laboratory services.
The goal?
- Reduce landfill waste from unused and expired clinical trial kits.
- Donate these high-quality medical supplies to communities with urgent healthcare needs.
Why This Matters
Clinical trials are vital for developing new therapies. But they often leave behind surplus kits—packed with perfectly good medical materials—that end up as waste.
Through Kits4Life, LabConnect will:
- Identify eligible kits from sponsors and clinical sites.
- Safely donate them to organizations serving under-resourced communities.
"We’re excited to partner with Kits4Life to give surplus kits a second life,"
- Julia Tarasenko, Chief Commercial & Strategy Officer at LabConnect.
Turning Strategy Into Action
LabConnect’s ESG approach covers:
- Carbon footprint reduction
- Ethical sourcing
- Community engagement
This new partnership takes that strategy a step further—transforming unused trial materials into life-saving resources.
Tarasenko adds: "Sustainability and innovation are not mutually exclusive—they strengthen each other. Partnerships like this show that environmental responsibility and breakthrough therapies can go hand in hand."
About LabConnect
LabConnect provides:
- Central Laboratory Services
- Functional Service Provider (FSP) and Scientific Consulting
- Data Integration and Transformation Services
Specialties include complex studies in immuno-oncology, cell and gene therapies, and rare diseases.
With world-class labs, advanced technology, and access to global markets, LabConnect offers an end-to-end solution for clinical trial lab services.
